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Objective The aim of this study was to determine the
surgical outcomes and renal function following salvage
surgery for bilateral Wilms tumor (BWT).
Summary background data The challenge for the
surgeon treating BWT lies in striking a fine balance
between renal preservation and oncological clearance.
Methods This is a retrospective review of medical records
in a tertiary care hospital in India. Nine children with BWT
who presented between 2005 and 2015 were reviewed and
followed up through telephone. Survival rates were
calculated using the Kaplan–Meier method. A P value of
less than 0.05 was considered statistically significant.
Results Seven (78%) of nine children were boys and two
(22%) were syndromic. Six (67%) children presented at
less than 1 year of age. Eight (89%) children presented with
an abdominal mass. There were no metastases at
presentation. All children underwent trucut biopsy and
neoadjuvant chemotherapy. Six children underwent
surgery: four underwent bilateral nephron sparing surgery
(NSS) and two underwent unilateral nephrectomy with
contralateral NSS. Tumor recurred in two children. The
mean follow-up was 38 months (range: 5–108 months).
Creatinine clearance (CrCl) improved postoperatively in all
children. Postoperative hypertension was transient and
resolved with improvement in CrCl.
Conclusion Children with BWT in the Indian subcontinent
may be younger than those in the rest of the world. NSS
yields good outcomes even for recurrences. Postoperative
hypertension is transient in the majority of patients and
correlated with improvement in CrCl. Prognosis is related
to operability and syndromic association. Ann Pediatr Surg
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Introduction
Wilms tumor is the most common renal malignancy
during childhood, with an incidence of 0.8 per 100 000
population. Approximately 5% of children have bilateral
synchronous involvement. These children are usually
younger than the unilaterally affected children and may
have syndromic associations with compromised baseline
renal functions.
Chemotherapy followed by nephron-sparing surgery
(NSS) has become the standard of care for children with
bilateral Wilms tumor (BWT). The oncosurgeon walks a
tight rope between organ preservation and tumor
clearance. Minimizing nephron loss is desirable in a
young child requiring chemotherapy, thus avoiding
hypertension and renal insufficiency. Renal parenchymal
preservation, however, may pose an increased risk for
recurrent disease. Here, we describe six children who
were operated for BWT.
Bradley et al. [1] first described the association of
hypertension with Wilms tumor in 1938. The incidence
of hypertension in children with Wilms tumor is
estimated to be between 50 and 90% [2]. The causal
relationship of hypertension with Wilms tumor is
supported by the reversal of hypertension after removal
of the tumor in 91% children [2]. The present study
examines renal outcomes and hypertension in children
with BWT following salvage surgery and discusses the
predicament faced by the surgical team treating these
children in a resource-limited environment.
Methods
A 10-year retrospective chart review was conducted of
children diagnosed with BWT between 2006 and 2015 at
Christian Medical College, Vellore. Patients were identi-
fied through an electronic search of hospital databases.
Nine children were identified, of whom six underwent
surgery. The demographic data, imaging, surgical proce-
dure, and related complications of the six children who
underwent surgery were analyzed. Families were con-
tacted through telephone to enquire about the child’s
current status.
All management decisions were made at a multidisci-
plinary tumor board consisting of pediatric surgeons,
pediatric oncologists, and radiation oncologists. Che-
motherapy was given according to the SIOP (Interna-
tional Society of Paediatric Oncology) protocol. NSS
included heminephrectomy, partial nephrectomy, and
enucleation. NSS was performed when a consensual
decision was made that at least one-third of renal tissue
could be spared. Renal function was estimated through
serial monitoring of creatinine clearance (CrCl) and mean
arterial pressure (MAP). Renal failure was defined by the
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need for dialysis or renal transplantation. CrCl was
calculated using the Schwartz formula: [k height
(cm)/creatinine (mg/dl)], where k is 0.55 and 0.45 for
children older and younger than 18 months, respec-
tively [3]. Postoperative treatment, consisting of adjuvant
chemotherapy with or without radiation, was given.
Cumulative survival analysis was performed using Kaplan–
Meier estimate for disease-free survival (DFS) and overall




Seven (78%) of nine children diagnosed with BWT during the
study period were boys. Two (22%) children were syndromic:
one child had Denys Drash syndrome and another had an
unspecified syndrome consisting of squint, macrocephaly,
hypotonia, and hypospadias. Six (67%) children presented at
less than 1 year of age. Eight (89%) children presented with
an abdominal mass with or without fever, vomiting, and failure
to thrive. One child presented with pyonephrosis and his
tumors were subsequently picked up on imaging following
percutaneous drainage. The clinical features of the six
operated children are summarized in Table 1. There were
no metastases at presentation.
Preoperative status
All children underwent a bilateral trucut biopsy followed by
neoadjuvant chemotherapy. All tumors were of a favorable
histology; WT1 gene was positive in six of seven patients
tested. Of the 12 renal units operated, 10 showed a mean
24% decrease in tumor size following chemotherapy. Two
renal units increased in size by an average of 16%. One of
these lesions showed rhabdomyoblastic differentiation and
the others had blastemal components.
A computed tomography (CT) was performed for all patients
after initial chemotherapy to measure response by change
in size and vascularity and plan surgery. A select group of
patients underwent a two-dimensional color Doppler to look
for vascular involvement or to confirm the presence of a
tumor thrombus.
Both syndromic children died before surgery. The child
with pyonephrosis failed to attend the outpatient
department for chemotherapy after diagnosis; the other
presented with septic shock and died before chemother-
apy could be initiated. Another child with nephrotic
syndrome failed to respond to second-line chemotherapy
and was referred for a renal transplant. He was lost to
follow-up.
Surgical management
Six children underwent surgery following chemotherapy.
The median time from diagnosis to surgery was 63 days
(range: 50–280 days). Both sides were operated at the
same time. Surgery was decided based on preoperative
imaging and intraoperative findings. Intraoperative ultra-
sound was used when NSS was planned. Bilateral NSS
was possible in four children (cases 1–3, 5). Cases 4 and 6
underwent unilateral nephrectomy and contralateral
NSS.
Surgical margins were negative in all patients. All tumors
were of favorable histology. Five of six tumors were WT1
positive.
Postoperative complications included urinomas requiring
percutaneous drainage in patients 1 and 2 and a urinary
tract infection in patient 3. The development of the
urinoma did not have any bearing on the long-term
function of the kidney.
Outcome
Functional outcome was monitored by serial CrCl and MAP
evaluations. CrCl preoperatively ranged from 59 to 217
(mean: 129). Postoperatively, there was an initial fall in CrCl,
followed by a steady rise in half of the children. The CrCl
was within normal limits for age at 1-year follow-up with an
average CrCl of 124 (range: 81–228). Figure 1a shows the
comparison of CrCl values for the six children at various
points in time.
Four of six patients were hypertensive preoperatively and
one additional child developed hypertension postopera-
tively. At 1-month follow-up, antihypertensive therapy
was stopped for three children, and 1 year later for
another child. One child required antihypertensives for
92 months. All surviving operated children are presently
normotensive and off medication. The median time to
resolution of hypertension postoperatively was 1 month
(interquartile range: 1–12 months). Figure 1b shows the
trend of MAPs in the six operated children. (For case 5,
only the hypertensive status was known but no MAP
value was available; therefore, he was not included in the
graph). Resolution of hypertension seemed to be
associated with improvement in CrCl.
Table 1 Clinical features of the six operated patients




(months) Right Left Right Left WT1 Preoperative
1
year Current Preoperative Postoperative
Maximum follow-
up (months) Recurrence Outcome
1 17 NSS NSS FH FH Positive 217 193 159 – TH 28 Nil Alive
2 10 NSS NSS FH FH Positive 189 171 228 + TH 29 Nil Alive
3 12 NSS NSS FH FH Positive 59 80 88 + + 108 Bilateral Alive
4 10 NSS Nephrectomy FH FH Negative 65 73 121 + TH 41 Nil Alive
5 48 NSS NSS FH FH FP 113 97 97.2 + – 10 Unilateral Died
6 6 NSS Nephrectomy FH FH P 130 NA 81 – – 5 Nil Died
Current refers to the value/status at last follow-up.
FH, favorable histology; FP, focally positive; NA, not applicable; NSS, nephron-sparing surgery; TH, transient hypertension.
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Two children had renal scintigrams on follow-up in view of
postoperative urinomas (cases 1 and 2). Despite the formation
of urinomas postoperatively both renograms showed good
uptake, outline, and drainage at 1-year follow-up.
The tumor recurred in two children. Case 3 (Fig. 2a)
developed recurrence on the right side 4 months after
bilateral NSS (Fig. 2b) and subsequently underwent a
right nephrectomy. Two years later he was found to have a
nodule in the left kidney (Fig. 2c), which was enucleated.
He is well at 108 months’ follow-up (Fig. 2d). Case 5
developed a skin nodule at the biopsy site 7 months after
surgery, which on evaluation revealed a widespread
recurrence in the right renal bed. His family opted for
alternative medicine and he died 3 months later.
The mean follow-up was 38 months (range: 5–108
months). The DFS was 63% at 3 years, which corre-
sponded to a mean DFS time of 28 months (95%
confidence interval of 13–42 months) (Fig. 3). The
overall survival at 3 years was 75%, which corresponded to
a mean survival period of 30 months (95% confidence
interval of 18–40 months).
Discussion
From a surgical perspective, BWT remains a challenge for
more than one reason. These children present at an
earlier age compared with those with unilateral Wilms
tumor. The mean age at presentation in our study was
16 months, which is younger than that reported else-
where [4–6]. Most children present with large abdominal
masses [4–8]. These predispose to recurrent aspiration
due to increased intra-abdominal pressure. Further,
administering chemotherapy in younger children with
renal impairment is not without risk. A high index of
suspicion is necessary for unusual presentations, as
highlighted in the child who presented with bilateral
pyonephrosis.
Imaging plays a crucial role in the preoperative planning,
especially for NSS. The use of-fluorine-18 fluorodeox-
yglucose PET or quantitative MRI preoperatively to
assess response and plan surgery are desirable [9]. We
found a combination of ultrasound and computed
tomography to be cost-effective and adequate. Intrao-
perative ultrasound is a useful adjunct to define the
extent of dissection required.
Preoperative chemotherapy is essential in NSS as the aim
is to safely preserve as much functional renal tissue as
possible. This has unified the SIOP and NWTS protocol
for BWT. Renal failure rates in NWTS-1 and NWTS-2
dropped from 16.4 to 3.8% respectively in NWTS-4 [10].
When the response to first-line chemotherapy is not
encouraging, second-line chemotherapy may be initiated.
Persistent unresponsiveness should raise suspicions of
non-Wilms renal tumors. These tumors may tend toward
needing renal replacement therapy (RRT). One child in
our study required second-line chemotherapy.
WT1 was positive in 86% tumors in this study. There was
no statistically significant difference in outcome in
relation to WT1. A long-term study on the clinical
relevance of WT1 mutations revealed no significant
difference in the overall survival of patients with and
those without WT1 mutations [10]. Contrary to this, Oue
et al. [5] reported higher rates of nephropathy in WT1
tumors in the long term. They suggested a minimum of
10-year follow-up after treatment completion. Likewise,
Royer-Pokora et al. [11] identified and increased risk for
bilateral tumors and second tumor events in those with
WT1 germline mutations, thereby advocating surveillance
until adulthood.
In the management of Wilms tumor, NSS is usually
reserved for BWT [12]. We found that the type of surgical
procedure used did not have a bearing on outcome. Several
groups advocate favoring a more NSS over achieving
negative surgical margins [4,10]. Positive surgical margins
do not necessarily lead to local recurrence as adjuvant
chemotherapy and radiation prevent the same [4,10].
Urine leak, pyelonephritis, and proteinuria are some of the
expected complications with NSS. Although three patients
developed complications, this did not affect their function
or survival. This is in accordance with the 2001 SIOP
report, which reported that, although the complications
with NSS are higher, the difference is not statistically
significant [13].
The development of hypertension has been a cause of
concern following bilateral renal surgery. We found that
two children required antihypertensives for more than a
Fig. 1
(a) Creatinine clearance (CC) trends over time. (b) Mean arterial
pressure (MAP) trends over time.
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month postoperatively (cases 1 and 3). The type of
operation did not seem to correlate with the need for
antihypertensives in our study as compared with the
study by Herbetus et al. [14], who found higher rates of
hypertension with unilateral NSS and contralateral
nephrectomy. However, our cohort is small and further
studies may be required to decide the best possible
outcome for children with BWT with regard to hyperten-
sion.
Further, in the same series, there was a decrease in the
prevalence of hypertension postoperatively (58.8–41.2%) [14].
Our results are similar, suggesting that hypertension is likely
multifactorial and may reflect tumor activity, tumor location,
and postoperative nephron preservation. The fact that an
individual’s hypertensive status is subject to change over
time should also be considered when analyzing variability
in results.
It is known that the Schwartz formula for CrCl calculation
is not routinely applicable to children below 2 years and is
further limited by its tendency to overestimate CrCl. This
explains some spuriously high CrCl values in our study.
However, as the comparison was within the same patients
as regards preoperative and postoperative CrCl, the trend
rather than the absolute value was considered to reflect
improvement or deterioration in renal function.
The preoperative range in CrCl varied among children
and there was no correlation between the actual value of
CrCl and development of hypertension. However, we
Fig. 2
Radiological images of patient 3. (a) Preoperative computed tomographic (CT) image of patient 3 showing bilateral large renal masses. (b) CT image
showing recurrence on the right side 4 months after bilateral nephron-sparing surgery. (c) Follow-up CT 2 years later showing the left renal
recurrence. (d) Ultrasonographic image at last follow-up demonstrating good left residual kidney.
Fig. 3
Kaplan–Meier plot depicting disease-free survival (DFS).
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found that, after the procedure, children with a low CrCl
required antihypertensives for a longer duration. CrCl
improved steadily (after an initial fall) in all patients
postoperatively, and correspondingly the need for anti-
hypertensive therapy decreased.
Lange et al. [15] reported that the incidence of end-stage
renal disease among nonsyndromic patients was 4.0% at
3 years from diagnosis in patients with synchronous BWT
and 19.3% in those with metachronous BWT. Recent
reports from NWTS indicate that the incidence of renal
failure in patients with BWT without associated anoma-
lies is 11.5% at 20 years [10]. During the course of follow-
up, none of our operated patients had renal failure or
required renal replacement therapy.
Besides the child with the recurrence who refused
further treatment, there was one other death in the
study (patient 6). The child died following an episode of
gastroenteritis 5 months after surgery. Opponents may
argue that the gastroenteritis precipitated acute renal
failure and that death was due to compromised renal
reserves; however, the postoperative renal function was
normal. As the cause of death was unrelated to the
primary disease, the event was considered as a competing
risk event. Competing risk events decrease the overall
survival, and, although rare, it must be borne in mind that
they can adversely affect survival rates.
Five-year DFS and overall survival rates are steadily
improving worldwide. Renal failure and recurrence are
the main factors affecting survival rates. NWTS-3 [16]
and NWTS-4 [10] indicated a 10-year overall survival of
69 and 78%, respectively, in BWT. Oue et al. [5] had
5- and 10-year survival rates, with normal renal function
being 85.1 and 52.8%, respectively. Our results are
comparable but are limited by the small cohort.
Conclusion
The surgical treatment of BWT is troubled by renal
insufficiency, hypertension, and the challenge of perform-
ing NSS. Our findings suggest that children with BWT in
the Indian subcontinent may be younger than the rest of
the world. NSS yields good outcomes even for recur-
rences. Postoperative hypertension is transient in the
majority of patients and correlated with improvement in
CrCl. Prognosis is related to operability and syndromic
association.
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